Advanced Enzyme Technologies Share Price Target 2026: Stock Analysis, Share Price Today, Bull Case and Bear Case After Q1 FY27
- May 13, 2026
- Posted by: Neeraj Pandey
- Category: News
Advanced Enzyme Technologies Rs 266.70 (12 Oct 2026 close). 52-week range Rs 251.95 to Rs 419. Q1 FY27 revenue Rs 202.81 cr, up 4%; profit Rs 38.59 cr, down 5%.
Quick Answer
The Advanced Enzyme Technologies share price target for 2026 is Rs 248 to Rs 314, which is between 7 percent below and 18 percent above the last close of Rs 266.70, with bull and bear cases of Rs 370 to Rs 448 and Rs 156 to Rs 195. Advanced Enzyme Technologies reported Q1 FY27 revenue of Rs 202.81 crore, up 4 percent from Rs 194.76 crore, and net profit of Rs 38.59 crore, down 5 percent from Rs 40.44 crore. Profit fell 15 percent from Rs 45.25 crore in Q4 FY26, and the stock trades at 17.4 times trailing earnings against an industry average of 36.7 times, with a dividend yield of 2.01 percent. No brokerage price target was available on the sources we track as of 12 October 2026, so every range below is a Univest research scenario.
The Advanced Enzyme Technologies share price target for 2026 is Rs 248 to Rs 314 in the Univest base case, with the stock at Rs 266.70 at the 12 October 2026 close. That is 36.3 percent below its 52-week high of Rs 419.00 and 5.9 percent above its 52-week low of Rs 251.95, and the stock moved down 14.8 percent over the past year. Advanced Enzyme Technologies makes specialty enzymes and probiotics and exports to more than 50 countries. Debt to equity is 0.02 and the dividend yield is 2.01 percent.
Three things changed since the last update: Q1 FY27 profit slipped 5 percent to Rs 38.59 crore on revenue of Rs 202.81 crore, up 4 percent, the stock has fallen 36 percent from its Rs 419 peak of the week of 11 May on heavy volumes, and it sits 6 percent above its 52-week low of Rs 251.95. This Advanced Enzyme Technologies stock analysis covers the Advanced Enzyme Technologies share price today, the Advanced Enzyme Technologies share price forecast for 2026, 2027 and 2030, the Q1 FY27 numbers, catalysts and risks, key price levels and an Advanced Enzyme Technologies buy or sell view.
Click Here – Get Free Investment Predictions
What Is the Advanced Enzyme Technologies Share Price Target for 2026?
The 2026 target for Advanced Enzyme Technologies shares is Rs 248 to Rs 314 in the Univest base case, which is -7.2% to +17.5% against the last close. The bull case is Rs 370 to Rs 448 and the bear case is Rs 156 to Rs 195. No brokerage price target was available on the sources we track as of 12 October 2026, so every range below is a Univest research scenario. Analyst consensus is used as a cross-check, not as the base.
Advanced Enzyme Technologies Share Price Target Scenarios: Bull Case, Base Case and Bear Case
| Scenario | FY28E EPS | Target Multiple | Price Target (Rs) | Move vs Rs 266.70 |
|---|---|---|---|---|
| Bull Case | Rs 19.5 | 19x to 23x | 370 to 448 | +38.9% to +68.2% |
| Base Case | Rs 16.5 | 15x to 19x | 248 to 314 | -7.2% to +17.5% |
| Bear Case | Rs 13 | 12x to 15x | 156 to 195 | -41.5% to -26.9% |
FY28 EPS of Rs 16.5 in the base case compares with trailing EPS of Rs 15.34 and Q1 EPS of Rs 3.31, and assumes low single-digit revenue growth with the net margin holding near 19 percent. Specialty enzyme makers with a return on equity near 10 percent trade at 15 to 19 times earnings in this scenario, close to the current 17.4 times and a discount to the 36.7 times industry average. The PE multiple of 17.4 times on trailing earnings sits against an industry average of 36.7 times, so the table also uses a FY28 EPS estimate, which is a Univest assumption and not company guidance. Those assumptions set the Advanced Enzyme Technologies share price target range around the current price.
Advanced Enzyme Technologies Company Overview and Share Price Today as of 12 October 2026
Advanced Enzyme Technologies share price today is Rs 266.70 on the NSE at the 12 October 2026 close, before the market opens on 13 October. The market capitalisation is Rs 2,985 crore, and the stock trades at 17.4 times earnings against an industry average of 36.7 times. The Univest base case Advanced Enzyme Technologies share price target of Rs 248 to Rs 314 is -7.2% to +17.5% from here. The table below sets out the key numbers behind the Advanced Enzyme Technologies share price target.
| Parameter | Value | Context |
|---|---|---|
| NSE Ticker | ADVENZYMES | BSE code 540025 |
| Sector | Enzymes and probiotics | Per Univest sector classification |
| Last Close (NSE) | Rs 266.70 | 12 Oct 2026 close |
| 52-Week High | Rs 419.00 | CMP is 36.3% below |
| 52-Week Low | Rs 251.95 | CMP is 5.9% above |
| 1-Year Return | About -15% | From about Rs 313.10 a year ago to Rs 266.70 |
| Market Capitalisation | Rs 2,985 crore | Small cap enzymes and probiotics company |
| Trailing P/E | About 17.4x | Industry P/E about 36.7x |
| P/B Ratio | About 1.83x | Book value Rs 145.72 per share |
| EPS (TTM) | Rs 15.34 | Trailing twelve months |
| Return on Equity | About 10.3% | Debt to equity 0.02 |
| Dividend Yield | About 2.01% | Regular dividend payer |
| 12-Month Target (Base Case) | Rs 248 to Rs 314 | Univest base case |
| Bull Case | Rs 370 to Rs 448 | +38.9% to +68.2% |
| Bear Case | Rs 156 to Rs 195 | -41.5% to -26.9% |
Track live price, fundamentals and results for Advanced Enzyme Technologies on the Univest Screener.
How Did Advanced Enzyme Technologies Perform in Q1 FY27?
Advanced Enzyme Technologies reported Q1 FY27 revenue of Rs 202.81 crore, up 4 percent from Rs 194.76 crore, and net profit of Rs 38.59 crore, down 5 percent from Rs 40.44 crore. EPS was Rs 3.31 against Rs 3.57. Together these Q1 FY27 numbers anchor the Advanced Enzyme Technologies share price target.
| Metric | Q1 FY27 | Context |
|---|---|---|
| Revenue | Rs 202.81 crore | Up 4.1% from Rs 194.76 crore; down 3.7% from Rs 210.60 crore in Q4 FY26 |
| Net Profit | Rs 38.59 crore | Down 4.6% from Rs 40.44 crore; down 14.7% from Rs 45.25 crore in Q4 FY26 |
| EPS | Rs 3.31 | Against Rs 3.57 in Q1 FY26 and Rs 3.84 in Q4 FY26 |
| Net Margin | 19.0% | Against 20.8% in Q1 FY26 |
| FY26 Revenue | Rs 780.59 crore | FY26 net profit Rs 173.61 crore |
Revenue grew only modestly and profit slipped, so the margin eased from 20.8 percent to 19.0 percent. The FY27 outlook depends on whether revenue growth returns to high single digits. The FY27 outlook is the main input for these estimates, so they anchor the Advanced Enzyme Technologies target price.
Why Is Advanced Enzyme Technologies Share Price Down 36 Percent From Its May High?
Advanced Enzyme Technologies shares are about 36 percent below the Rs 419 peak of the week of 11 May 2026, when 94.9 lakh shares traded, and down about 15 percent over twelve months. Heavy volumes followed on the way down, with 67 lakh shares traded in the week of 29 June as the price fell from Rs 348 to Rs 318, and no cause was confirmed in the exchange data we track.
The close of Rs 266.70 is only 6 percent above the 52-week low of Rs 251.95. Growth in Q1 FY27 was slow and profit slipped, so the Advanced Enzyme Technologies share price target scenarios below treat the stock as a steady earner priced for modest growth.
Key Catalysts for the Advanced Enzyme Technologies Share Price Target in 2026
4 catalysts matter most for the Advanced Enzyme Technologies share price target, and sector tailwinds in enzymes and probiotics are part of the case. Together they decide whether the base case is reached.
1. Probiotics and Enzymes Demand
Specialty enzymes and probiotics serve human nutrition, animal nutrition, food and other industries in more than 50 countries. Rising demand for gut health products supports volumes. If it plays out, the Advanced Enzyme Technologies share price target moves toward the top of the base range.
2. Margin Resilience
Net margin of 19.0 percent in Q1 is high for a manufacturer. Holding it supports EPS near Rs 16.5. Strength here would support the upper end of the Advanced Enzyme Technologies target price.
3. Debt-Free Balance Sheet
Debt to equity of 0.02 and a dividend yield of 2.01 percent give a cushion while growth is slow. Delivery on this point keeps the Advanced Enzyme Technologies share price target on track.
4. Valuation Support
A trailing PE of 17.4 times against an industry average of 36.7 times, and 1.8 times book, leaves room for a re-rating if growth picks up. Better news here would lift the Advanced Enzyme Technologies target price toward the bull case.
What Are the Key Risks to the Advanced Enzyme Technologies Share Price Target?
The main risks are slow growth, falling profit, a persistent downtrend and currency and input costs. Each can pull the Advanced Enzyme Technologies share price target lower.
Slow Growth
Revenue grew only 4 percent in Q1 FY27 and fell 4 percent from Q4 FY26. Growth this slow limits the multiple. If it materialises, the Advanced Enzyme Technologies share price target would slip toward the bear case.
Falling Profit
Profit fell 5 percent from a year ago and 15 percent from Q4 FY26. Further declines would cut the EPS estimate. This is the main downside risk to the Advanced Enzyme Technologies target price.
Persistent Downtrend
The stock has fallen 36 percent from its May peak on heavy volumes. The trend stays negative until it holds above Rs 278.40. A worsening here would cut the Advanced Enzyme Technologies share price target toward the low end of the range.
Currency and Input Costs
Export sales make earnings sensitive to the rupee, and raw material costs can move margin. Watch it closely, because it can pull the Advanced Enzyme Technologies target price lower quickly.
Advanced Enzyme Technologies Stock Analysis: Support and Resistance Levels for the Share Price Target
Advanced Enzyme Technologies stock analysis on weekly charts shows the stock holding between Rs 264 and Rs 278.40, just above the 52-week low of Rs 251.95.
The first support level is Rs 264, the area of the recent weekly lows. Below that, Rs 252 is the 52-week low zone.
The first resistance level is Rs 278.40, near the highs of recent weeks. Above that, Rs 291.20 is the next resistance zone, well below the Rs 419 May peak. These levels come from weekly price action, are not trade recommendations, and frame the near-term Advanced Enzyme Technologies share price target.
Advanced Enzyme Technologies Share Price Target 2026, 2027 and 2030: Short, Medium and Long Term
Short-Term Advanced Enzyme Technologies Share Price Target (3 to 6 Months)
In the near term the stock is likely to trade between Rs 264 and Rs 278.40. A close above Rs 278.40 would put Rs 291.20 in play, while a weekly close under Rs 264 would open a slide toward Rs 252. Q2 FY27 results and export demand are the main triggers. This range anchors the near-term Advanced Enzyme Technologies share price target.
12-Month and 2027 Advanced Enzyme Technologies Share Price Target
The 12-month target price is Rs 248 to Rs 314, valued on 15 to 19 times Rs 16.5 of FY28 EPS. The Advanced Enzyme Technologies stock price target 2027 follows the same base case, and the range across scenarios runs from Rs 156 in the bear case to Rs 448 in the bull case.
Long-Term Advanced Enzyme Technologies Share Price Target for FY29 to 2030
For FY29 to 2030 the Univest scenario range is Rs 270 to Rs 370. This assumes EPS of Rs 18 in FY29 and Rs 19.5 in FY30 and a multiple of 15 to 19 times. It needs revenue growth to reach high single digits, margin to hold near 19 percent and probiotics sales to scale. This is the long-term Advanced Enzyme Technologies share price target in the Univest scenarios.
Bull Case and Bear Case for Advanced Enzyme Technologies Share Price Target
Bull Case Rs 370 to Rs 448
The bull case of Rs 370 to Rs 448 for the Advanced Enzyme Technologies share price target needs Rs 19.5 of EPS and the market to pay 19 to 23 times for it. That needs growth to re-accelerate and the market to pay 19 to 23 times earnings, as it did on the way to the Rs 419 May peak. It is +38.9% to +68.2% from the last close.
Bear Case Rs 156 to Rs 195
The bear case of Rs 156 to Rs 195 for the Advanced Enzyme Technologies share price target equals 12 to 15 times Rs 13 of FY28 EPS. That assumes profit falls toward Rs 13 per share and the multiple compresses to 12 to 15 times, well below the Rs 251.95 low. It is -41.5% to -26.9% from the last close.
Is Advanced Enzyme Technologies a Good Buy at Rs 267? Advanced Enzyme Technologies Buy or Sell View
Whether Advanced Enzyme Technologies is a buy at Rs 266.70 depends on horizon and risk appetite. The base case sits between 7 percent below and 18 percent above the current price, the stock is 36 percent below its high, and the open question is whether growth returns. The Advanced Enzyme Technologies share price target range is the starting point for that decision.
Long-term holders may focus on the dividend, margin and the balance sheet, and treat Rs 251.95 as the level to watch. Short-term traders may prefer to wait for a close above Rs 278.40, since the trend is down. Check institutional holding in the September quarter filing for signs of accumulation or selling. Consult a SEBI-registered advisor before acting, since this Advanced Enzyme Technologies buy or sell view is educational and the Advanced Enzyme Technologies price target is a Univest scenario.
How to Invest in Advanced Enzyme Technologies Shares
Step 1: Check the live price, valuation and the latest Advanced Enzyme Technologies share price target range on the Univest Screener.
Step 2: Open a demat and trading account with a SEBI-registered broker such as Univest before acting on any Advanced Enzyme Technologies share price target.
Step 3: Search for ADVENZYMES on the NSE or 540025 on the BSE in your trading app.
Step 4: Place a limit order near your planned entry and size the position so a fall to Rs 156 is bearable.
Step 5: Track revenue growth, net margin and Q2 FY27 results and set price alerts on the Univest App to follow any change in the Advanced Enzyme Technologies share price target.
Conclusion
Advanced Enzyme Technologies closed at Rs 266.70 against a Univest base case share price target of Rs 248 to Rs 314, a bull case of Rs 370 to Rs 448 and a bear case of Rs 156 to Rs 195. Q1 FY27 delivered revenue of Rs 202.81 crore, up 4 percent, and net profit of Rs 38.59 crore, down 5 percent. The main risks are slow growth, falling profit, a persistent downtrend and currency and input costs.
The stock is 36.3 percent below its 52-week high, so the base case sits between 7 percent below and 18 percent above the current price. The triggers to watch are revenue growth, net margin and Q2 FY27 results and the Rs 264 and Rs 278.40 levels. Re-check the Advanced Enzyme Technologies share price target after each quarterly result. Investors with a long horizon and tolerance for volatility can track these triggers, while others may prefer to size positions carefully.
Download the Univest iOS App or Univest Android App to track Advanced Enzyme Technologies live price and get daily stock recommendations.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on Advanced Enzyme Technologies Share Price Target 2026
What is the Advanced Enzyme Technologies share price target for 2026?
Ans. The Advanced Enzyme Technologies share price target for 2026 is Rs 248 to Rs 314 in the Univest base case, with a bull case of Rs 370 to Rs 448 and a bear case of Rs 156 to Rs 195. No brokerage target was available on the sources we track as of 12 October 2026, so these are Univest research scenarios. These are estimates and can change after the Q2 FY27 results.
What is the Advanced Enzyme Technologies share price target for 2027?
Ans. The Advanced Enzyme Technologies share price target for 2027 is Rs 248 to Rs 314 in the base case, valued on 15 to 19 times Rs 16.5 of FY28 EPS. The scenario range runs from Rs 156 to Rs 448.
Is Advanced Enzyme Technologies a good buy at Rs 266.70?
Ans. Whether Advanced Enzyme Technologies is a good buy at Rs 266.70 depends on your horizon, risk appetite and how you read the Advanced Enzyme Technologies share price target. The stock trades at 17.4 times earnings with a 2.01 percent dividend yield and almost no debt, but growth is slow and the trend is down. Consult a SEBI-registered advisor before investing.
What are the key risks to the Advanced Enzyme Technologies share price target?
Ans. The key risks are slow growth, falling profit, persistent downtrend and currency and input costs. Revenue grew only 4 percent and profit fell 5 percent in Q1 FY27, and the stock is in a downtrend.
What are the key catalysts for the Advanced Enzyme Technologies share price target?
Ans. The key catalysts are probiotics and enzymes demand, margin resilience, Debt-Free balance sheet and valuation support. A dividend yield of 2.01 percent, a net margin near 19 percent and a PE of 17.4 times against an industry 36.7 times are the main supports.
Where can I track Advanced Enzyme Technologies share price today and Advanced Enzyme Technologies share price target updates?
Ans. You can track the live Advanced Enzyme Technologies share price, results and any change to the Advanced Enzyme Technologies share price target on the Univest Screener and the Univest App. Download the Univest iOS App or Univest Android App for research from SEBI-registered analysts.
What are Advanced Enzyme Technologies’ 52-week high and low?
Ans. Advanced Enzyme Technologies’ 52-week high is Rs 419.00 and its 52-week low is Rs 251.95, based on NSE data. At Rs 266.70 the stock is 36.3 percent below the high and 5.9 percent above the low. Both levels frame the target range.
How to buy Advanced Enzyme Technologies shares?
Ans. Open a demat account with a SEBI-registered broker such as Univest, search for ADVENZYMES on the NSE or 540025 on the BSE, and place a limit order near your entry price, using the Advanced Enzyme Technologies share price target range as a guide. Size the position so a fall to Rs 156 is bearable, and check the live price on the Univest Screener first.
